The effects of kappa opioid agonist RU-1205 on local field potentials and behavior in the discriminative stimulus paradigm by K. Yu. Kalitin, O. Yu. Mukha, A. A. Spasov

Get full text

Models of neuroinflammation for the assessment of kappa-opioid receptor ligands by K. Yu. Kalitin, A. A. Spasov, O. Yu. Mukha

Get full text

Electrophysiological effects of kappa-opioid analgesic, RU-1205, using machine learning methods by K. Yu. Kalitin, O. Yu. Mukha, A. A. Spasov

Get full text

HEMORHEOLOGICAL PROPERTIES OF THE 5-HT2A-ANTAGONIST OF THE 2-METHOXYPHENYL-IMIDAZOBENZIMIDAZOLE DERIVATIVE OF THE RU-31 COMPOUND AND CYPROHEPTADINE, IN COMPARISON WITH PENTHOXYPHYL... by D. S. Yakovlev, L. V. Naumenko, K. T. Sultanova, A. A. Spasov

Get full text

Effects of a New Kappa Agonist (Fluorophenyl Derivative of Imidazo[1,2-<i>а</i>]benzimidazole) on the Rat Genome by O. V. Verle, A. G. Sirekanyan, N. V. Eliseeva, Yu. V. Lifanova, A. A. Spasov, O. V. Ostrovsky

Get full text

PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION by A. A. Spasov, L. A. Smirnova, O. Yu. Grechko, N. V. Eliseeva, Yu. V. Lifanova, A. I. Rashchenko, O. N. Zhukovskaya, A. S. Morkovnik, V. A. Anisimova

Get full text

DF-5 COMPOUND DELAYS DEVELOPMENT OF DIABETIC NEPHROPATHY IN RATS by A. A. Spasov, O. N. Zhukovskaya, A. I. Rashchenko, A. A. Brigadirova, R. A. Litvinov, N. A. Gurova, A. V. Smirnov, N. G. Pan’shin, H. S.A. Abbas, A. S. Morkovnik

Get full text